. . . . . . . . "No effect on endoproteolytic cleavage. No effect on APP processing. Impaired NOTCH1 processing. Greatly reduced Abeta42/Abeta40 ratio." . . . . . "No effect on endoproteolytic cleavage. No effect on APP nor NOTCH1 processing." . "431"^^ . . "431"^^ . . . . . . "No effect on endoproteolytic cleavage. No effect on APP processing. Impaired NOTCH1 processing. Some increase in Abeta42/Abeta40 ratio." . "431"^^ . . "431"^^ . . "431"^^ . . "431"^^ . . . . . . "No endoproteolytic cleavage. No APP nor NOTCH1 processing. No detectable Abeta." . "431"^^ . . "431"^^ . . . . . . "Greatly reduced endoproteolytic cleavage. Very little APP and NOTCH1 processing. Very low levels of Abeta40 and no detectable Abeta42." . "431"^^ . . "431"^^ . . "Mutagenesis site occurs in NX_P49768-2 at amino acids 431 - 431." . . . . . . . . . "neXtProt gold" . . . . . . . . . . . . . . . . . . . . . . . . . "2014-09-19T00:00:00.0Z"^^ . . . "neXtProt database" . "CALIPHO project" . . . . . "1" . . . . . . . . . . .